PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.49%
Negative revenue growth while 3088.T stands at 4.11%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-1.92%
Negative gross profit growth while 3088.T is at 3.45%. Joel Greenblatt would examine cost competitiveness or demand decline.
-2.60%
Negative EBIT growth while 3088.T is at 3.84%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-4.40%
Negative operating income growth while 3088.T is at 1.87%. Joel Greenblatt would press for urgent turnaround measures.
-3.10%
Negative net income growth while 3088.T stands at 17.06%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-3.10%
Negative EPS growth while 3088.T is at 17.05%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-3.10%
Negative diluted EPS growth while 3088.T is at 17.05%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-42.18%
Negative OCF growth while 3088.T is at 653.10%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-72.49%
Negative FCF growth while 3088.T is at 1977.48%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
20.90%
Positive 10Y revenue/share CAGR while 3088.T is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
20.90%
Positive 5Y CAGR while 3088.T is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
20.90%
Positive 3Y CAGR while 3088.T is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
89.60%
Net income/share CAGR 1.25-1.5x 3088.T's 60.99%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
89.60%
5Y net income/share CAGR 1.25-1.5x 3088.T's 60.99%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
89.60%
3Y net income/share CAGR 1.25-1.5x 3088.T's 60.99%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.